LBX Pharmacy Chain Joint Stock Company

LBX Pharmacy Chain Joint Stock Company

603883.SS
LBX Pharmacy Chain Joint Stock CompanyCN flagShanghai Stock Exchange
11.69
CNY
+0.22
- -
8.87BMarket Cap

Total Valuation

LBX Pharmacy Chain Joint Stock Company carries a market capitalization of 8.87B, placing it among publicly traded companies globally. Its enterprise value stands at 19.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap8.87B
Enterprise Value19.24B

Share Statistics

LBX Pharmacy Chain Joint Stock Company currently has 760.10M shares outstanding.

Shares Outstanding760.10M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

LBX Pharmacy Chain Joint Stock Company trades at a trailing price-to-earnings ratio of 38.52. The price-to-sales ratio is 0.72, and the price-to-book ratio stands at 3.39.

PE Ratio38.52
PS Ratio0.72
PB Ratio3.39
P/TBV Ratio27.99
P/FCF Ratio33.74
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, LBX Pharmacy Chain Joint Stock Company trades at an EV/EBITDA multiple of 18.32 and an EV/FCF ratio of 40.69. The EV/Sales ratio of 0.87 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.32 provides insight into valuation relative to core operating earnings.

EV / Sales0.87
EV / EBITDA18.32
EV / EBIT18.32
EV / FCF40.69

Financial Position

LBX Pharmacy Chain Joint Stock Company maintains a current ratio of 0.84, meaning it holds 0.8x the short-term assets needed to cover near-term liabilities.

Current Ratio0.84
Quick Ratio0.22
Debt / Equity70.09
Debt / EBITDA4.80
Interest CoverageN/A

Financial Efficiency

LBX Pharmacy Chain Joint Stock Company posts a return on equity of 8.93 and a return on invested capital of 5.99.

Return on Equity (ROE)8.93
Return on Assets (ROA)2.01
Return on Invested Capital (ROIC)5.99
Return on Capital Employed (ROCE)2.42
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover4.00

Taxes

Over the trailing twelve months, LBX Pharmacy Chain Joint Stock Company has paid 211.99M in income taxes, reflecting an effective tax rate of 27.00.

Income Tax211.99M
Effective Tax Rate27.00

Stock Price Statistics

LBX Pharmacy Chain Joint Stock Company's stock has declined approximately -41.57921% over the past 52 weeks. The 50-day moving average sits at 12.52, while the 200-day moving average is 14.65.

Beta (5Y)N/A
52-Week Price Change-41.57921%
50-Day Moving Average12.52
200-Day Moving Average14.65
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, LBX Pharmacy Chain Joint Stock Company generated 22.19B in revenue and converted that into 414.22M in net income, yielding earnings per share of 0.75. EBITDA reached 1.05B, while operating income came in at 1.05B.

Revenue22.19B
Gross Profit7.23B
Operating Income1.05B
Pretax Income785.20M
Net Income414.22M
EBITDA1.05B
EBIT1.05B
Earnings Per Share (EPS)0.75

Balance Sheet

LBX Pharmacy Chain Joint Stock Company holds 2.22B in cash and equivalents against 5.04B in total debt, resulting in a net debt position of 241.69M. Total book value stands at 4.71B, with working capital of -1.66B providing operational flexibility.

Cash & Cash Equivalents2.22B
Total Debt5.04B
Net Debt241.69M
Equity (Book Value)4.71B
Book Value Per Share6.20
Working Capital-1.66B

Cash Flow

After subtracting -472.98M in capital expenditures, free cash flow totaled -472.98M - equivalent to -0.62 per share.

Operating Cash FlowN/A
Capital Expenditures-472.98M
Free Cash Flow-472.98M
FCF Per Share-0.62

Margins

LBX Pharmacy Chain Joint Stock Company operates with a gross margin of 32.56, reflecting its pricing power and cost economics. The operating margin of 4.73 and net profit margin of 1.87 provide insight into operational efficiency.

Gross Margin32.56
Operating Margin4.73
Pretax Margin3.54
Profit Margin1.87
EBITDA Margin4.73

Dividends & Yields

The company's payout ratio of 70.85 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.68
Dividend YieldN/A
Payout Ratio70.85
Shareholder Yield14.22
FCF Yield2.96

Stock Splits

LBX Pharmacy Chain Joint Stock Company's most recent stock split took place on June 27, 2024 with a 10:13 split ratio.

Last Split Date6/27/2024
Split Ratio10:13

Scores

LBX Pharmacy Chain Joint Stock Company posts an Altman Z-Score of 2.87, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.87